| 1 |
Correlation of red marrow radiation dosimetry with myelotoxicity: Empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and clinical settings |
|
| | Behr TM, Behe M, Sgouros G | | | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2002; 17 (4): 445-464 | | | [Pubmed] [Google Scholar] | | | 2 |
Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers |
|
| | Bastit L, Blot E, Debourdeau P, et al. | | | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001; 49 (1): 139-146 | | | [Pubmed] [Google Scholar] | | | 3 |
The statistics pause. Chapter V: Parametric tests |
|
| | Tasu, J.-P. | | | Feuillets de Radiologie. 2001; 41(1): 75-77 | | | [Pubmed] [Google Scholar] | | | 4 |
Studies on the red marrow dosimetry in radioimmunotherapy: An experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters |
|
| | Behr TM, Sgouros G, Stabin MG, et al. | | | CLINICAL CANCER RESEARCH. 1999; 5 (10): 3031-3043 | | | [Pubmed] [Google Scholar] | | | 5 |
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab fragments in a human colonic cancer model |
|
| | Behr TM, Behe M, Stabin MG, et al. | | | CANCER RESEARCH. 1999; 59 (11): 2635-2643 | | | [Pubmed] [Google Scholar] | |
|
